Biomira sets up synthetic biologics unit to meet demand for vaccine technology

EDMONTON (CP) - Cancer vaccine developer Biomira Inc. has set up a separate unit to profit from growing demand for synthetic biological products used to produce vaccines, shareholders were told Wednesday....More